SPSylvie D. Price

Sylvie D. Price

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sylvie D. Price has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Does ongoing general practitioner care in elderly patients help reduce the risk of unplanned hospitalization related to Beers potentially inappropriate medications?

    by Sylvie D Price, C D'ARcy J Holman, Frank M Sanfilippo, Jon D Emery

    Aim: To compare estimates of unplanned hospitalizations associated with exposure to Beers potentially inappropriate medications (PIM) in elderly people receiving different levels of ongoing general practitioner (GP) care.Methods: Using the pharmaceutical claims and other linked health data of 245 436 Western Australians aged ≥65 years with one or more claims for a medication from a PIM‐related drug class (1993–2005), we applied an enhanced case–time–control design to obtain odds ratios (OR) for unplanned hospitalization, from which attributable fractions, numbers, proportions and rates of admissions related to PIM exposure were derived.Results: Overall, 383 150 unplanned hospitalizations (“index subjects”) were identified. PIM exposure was associated with a similar relative risk of unplanned hospitalization in elderly people receiving the lowest and highest levels of ongoing GP care, but with a decreasing risk in the three highest tiers; adjusted OR (95% CI; attributable fractions) were 1.15 (1.09–1.21; 12.9%), 1.36 (1.27–1.46; 26.6%), 1.20 (1.15–1.26; 16.9%) and 1.13 (1.09–1.17; 11.4%) for groups from the lowest to highest levels. However, those with higher GP coverage had higher rates of PIM‐related hospitalization. Similar patterns were shown for commonly used high‐risk PIM (temazepam, diazepam, oxazepam, naproxen and digoxin).Conclusions: Increased requirement for ongoing GP contact in less healthy elderly people appears to help minimize their risk of unplanned hospitalization due to PIM‐related harm. GPs should continue to avoid Beers medications in older patients where possible, given their greater predisposition to medication exposure (including PIM) and adverse drug events. Nevertheless, close monitoring of elderly patients who need to use PIM should prove beneficial. Geriatr Gerontol Int 2015; 15: 1031–1039.


  • Are older Western Australians exposed to potentially inappropriate medications according to the Beers Criteria? A 13‐year prevalence study

    by Sylvie D Price, C D'ARcy J Holman, Frank M Sanfilippo, Jon D Emery

    Aim: To examine time trends and factors associated with exposure to potentially inappropriate medications (PIMs) by the Beers Criteria.Methods: PIM consumption days accumulated from the pharmaceutical claims of 251 305 Western Australians aged ≥65 years (1993–2005) and person follow‐up times produced counts/rates. Logistic/Poisson regression generated odds/rate ratios.Results: A total of 187 616 participants (74.7%) took ≥1 PIM (1993–2005), the cohort consuming 109 415 PIM daily doses/1000 person‐years. Annual exposure decreased from 45–47% to 40%, and annual consumption rate declined from 117 836 to 90 364 daily doses/1000 person‐years. Temazepam had the highest exposures (>17 000 daily doses/1000 person‐years). Number of medications taken (OR 35.03; 95% CI 34.37–35.71 for ≥10 vs. 0–2 drugs), annual drug intake (2.08; 2.04–2.12 for highest vs. lowest quartile), and high‐level residential aged care (1.96; 1.91–2.01) were most predictive of PIM exposure.Conclusions: PIM exposure remains high in older Western Australians. Our findings identify patients most at risk and medications to consider on Australia‐specific PIM lists.


  • Impact of Specific Beers Criteria Medications on Associations between Drug Exposure and Unplanned Hospitalisation in Elderly Patients Taking High-Risk Drugs: A Case-Time-Control Study in Western Australia

    by Sylvie D. Price, C. D’aRcy J. Holman, Frank M. Sanfilippo, Jon D. Emery

    Certain broad medication classes have previously been associated with high rates of hospitalisation due to related adverse events in elderly Western Australians, based on clinical coding recorded on inpatient summaries. Similarly, some medications from the Beers Criteria, considered potentially inappropriate in older people, have been linked with an increased risk of unplanned hospitalisation in this population. Our objective was to determine whether risk estimates of drug-related hospitalisations are altered in elderly patients taking ‘high-risk drugs’ (HRDs) when specific Beers potentially inappropriate medications (PIMS) are taken into consideration. Using the pharmaceutical claims of 251,305 Western Australians aged ≥65 years (1993–2005) linked with other health data, we applied a case-time-control design to estimate odds ratios (ORs) for unplanned hospitalisations associated with anticoagulants, antirheumatics, opioids, corticosteroids and four major cardiovascular drug groups, from which attributable fractions (AFs), number and proportion of drug-related admissions were derived. The analysis was repeated, taking into account exposure to eight specific PIMs, and results were compared. A total of 1,899,699 index hospitalisations were involved. Of index subjects, 12–57 % were exposed to each HRD at the time of admission, although the proportions taking both an HRD and one of the selected PIMs were much lower (generally ≤2 %, but as high as 8 % for combinations involving temazepam and for most PIMs combined with hypertension drugs). Included PIMs (indomethacin, naproxen, temazepam, oxazepam, diazepam, digoxin, amiodarone and ferrous sulphate) all tended to increase ORs, AFs and drug-related hospitalisation estimates in HRD combinations, although this was less evident for opioids and corticosteroids. Indomethacin had the greatest overall impact on HRD ORs/AFs. Indomethacin (OR 1.40; 95 % confidence interval [CI] 1.27–1.54) and naproxen (OR 1.22; 1.14–1.31) were associated with higher risks of unplanned hospitalisation than other antirheumatics (overall OR 1.09; 1.06–1.12). Similarly, among cardiac rhythm regulators, amiodarone (OR 1.22; 1.13–1.32) was riskier than digoxin (OR 1.08; 1.04–1.13). For comparisons of drug-related hospitalisation estimates, temazepam yielded the greatest absolute increases, especially with hypertension drugs. Indomethacin and temazepam should be prescribed cautiously in elderly patients, especially in drug combinations. Furthermore, it appears other antirheumatics should be favoured over indomethacin/naproxen and, in situations where both drugs may be appropriate, digoxin over amiodarone. Our methodology may help assess the safety of new medications in drug combinations in preliminary pharmacovigilance investigations.


  • Association Between Potentially Inappropriate Medications From the Beers Criteria and the Risk of Unplanned Hospitalization in Elderly Patients

    by Sylvie D. Price, C. D’ARcy J. Holman, Frank M. Sanfilippo, Jon D. Emery

    Background: Predisposition to adverse drug events with advancing age has led to the development of lists of potentially inappropriate medications (PIMs) to be avoided in the elderly, such as the Beers Criteria. The prevalence of Beers medications has been studied widely, but it is still unclear whether PIM use is predictive of adverse events in older people. Objectives: To examine potential associations between exposure to PIMs from the general Beers list and unplanned hospitalizations in elderly Western Australians. Methods: Using an enhanced case-time-control design and conditional logistic regression applied to the pharmaceutical claims and other linked health data of 251 305 Western Australians aged ≥65 years (1993-2005), odds ratios for unplanned hospitalization were obtained, from which attributable fractions, number and proportion of hospitalizations associated with drug exposure were derived. Results: Based on the health profiles of 383 150 hospitalized index subjects, overall PIM exposure was associated with an elevated risk of unplanned hospitalization (adjusted odds ratio = 1.18; 95% confidence interval = 1.15-1.21), this estimated risk increasing with the number of different PIMs and PIM quantity taken. Fifteen percent of unplanned hospitalizations in exposed index subjects (1980 per year) were attributed to PIM exposure. Patients taking meperidine (pethidine), nitrofurantoin, promethazine, indomethacin, and thioridazine appeared to be at particularly high risk of unplanned hospitalization, whereas temazepam, oxazepam, diazepam, digoxin, amiodarone, ferrous sulfate, and naproxen were attributed the greatest numbers of unplanned hospitalizations. Conclusions: Due caution prescribing Beers medications in the elderly seems justified, paying particular attention to PIMs listed above and to the concurrent use of multiple PIMs. Our results also support the retention of specific medications on PIM lists in future developments.


  • Are high-care nursing home residents at greater risk of unplanned hospital admission than other elderly patients when exposed to Beers potentially inappropriate medications?

    by Sylvie D Price, C D'ARcy J Holman, Frank M Sanfilippo, Jon D Emery

    To compare the risk of unplanned hospitalization in high-care nursing home residents taking Beers potentially inappropriate medications (PIM) against that of other elderly. Using an enhanced case-time-control design and conditional logistic regression applied to the pharmaceutical claims and other linked data of 245436 Western Australians aged ≥ 65 years (1993-2005), the study derived odds ratios for unplanned hospitalization in each group, from which attributable fractions, numbers, proportions and rates of PIM-related admissions were derived. Overall, 383150 unplanned hospitalizations were identified. PIM exposure was associated with a similar proportional increase in unplanned hospitalizations in high-care nursing home residents as in other older people; adjusted OR 1.21 (95% CI 1.10-1.34; attributable fraction 17.5%) versus OR 1.19 (95% CI 1.16-1.21; attributable fraction 15.7%). However, high-care nursing home residents had much higher estimated rates of hospitalizations attributed to Beers medications than other elderly (3951 vs 1394 per 100000 person-years). The relative risk of unplanned hospitalization rose similarly in both groups with increasing numbers of different PIM taken (OR 5.1 for 10 vs 0 PIM), but was affected more markedly by 3-month PIM consumption in nursing home residents (OR 4.85, 95% CI 2.40-9.83 for 900 vs 0 PIM daily doses) than in other older adults (OR 2.10, 95% CI 1.73-2.55). High-care nursing home residents do not appear to have a greater relative risk of unplanned hospitalization when given PIM, but do incur a higher absolute burden than other older adults. Physicians should exert caution with Beers medications in all older patients, restricting the number of different PIM and PIM quantity prescribed whenever possible.


  • Use of case–time–control design in pharmacovigilance applications: exploration with high‐risk medications and unplanned hospital admissions in the Western Australian elderly

    by Sylvie D. Price, C. D'ARcy J. Holman, Frank M. Sanfilippo, Jon D. Emery

    Purpose: To use a case–time–control design to derive preliminary estimates of unplanned hospitalisations attributable to suspected high‐risk medications in elderly Western Australians.Methods: Using pharmaceutical claims linked to inpatient and other health records, the study applied a case–time–control design and conditional logistic regression to estimate odds ratios (ORs) for unplanned hospital admissions associated with anticoagulants, antirheumatics, opioids, corticosteroids and four major groups of cardiovascular drugs. Attributable fractions (AFs) were derived from the ORs to estimate the number and proportion of admissions associated with drug exposure. Results were compared with those obtained from a more conventional method using International Classification of Diseases (ICD) external cause codes to identify admissions related to adverse drug events.Results: The study involved 1 899 699 index hospital admissions. Six of the eight drug groups were associated with an increased risk of unplanned hospitalisation, opioids (adjusted OR = 1.81, 95%CI 1.75–1.88; AF = 44.9%) and corticosteroids (1.48, 1.42–1.54; 32.2%) linked with the highest risks. For all six, the estimated number of hospitalisations attributed to the medication in the exposed was higher (two to 31‐fold) when derived from the case–time–control design compared with identification from ICD codes.Conclusions: This study provides an alternative approach for identifying potentially harmful medications and suggests that the use of ICD external causes may underestimate adverse drug events. It takes drug exposure into account, can be applied to individual medications and may overcome under‐reporting issues associated with conventional methods. The approach shows great potential as part of a post‐marketing pharmacovigilance monitoring system in Australia and elsewhere. Copyright © 2013 John Wiley & Sons, Ltd.